Skip to main content
. 2015 Jun 15;2015(6):CD006142. doi: 10.1002/14651858.CD006142.pub3

Treacy 2011.

Methods Type of study: randomised, placebo controlled design (pilot study).
Condition and number of participants randomised: 12 adults admitted for IV antibiotics with acute lung pain (VAS score > 4/10)
Groups: active TENS and placebo TENS
Participants Demographics: N = 12; age and gender information not available.
Setting: Northern Ireland; hospital inpatient setting.
Inclusion: TENS naive.
Exclusion: information not available.
Withdrawals/dropouts: information not available.
Interventions Where applied: information not available.
Applied by: information not available.
Waveform: information not available.
Frequency: 150 Hz.
Pulse duration: 200 ms.
Pulse amplitude/Intensity: information not available.
Electrodes:Information not available.
Duration and frequency of Rx: the duration of the lung pain.
Device/manufacturer: information not available.
Adverse effects: information not available.
Outcomes Pain outcome: VAS for pain intensity, before and after Rx.
ITT/per protocol analysis: not detailed.
Statistical analysis: statistically significant reduction in VAS scores post Rx in both groups.
Notes